{"nct_id":"NCT02654132","title":"An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2016-03-18","start_date_type":"ACTUAL","primary_completion_date":"2018-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}